Drug
Levodopa Carbidopa
Levodopa Carbidopa: highest development phase Post-Market, developed by Sandoz. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Sandoz
Trials
| Drug | Phase | Indication |
|---|---|---|
| Levodopa/Carbidopa(200mg/50mg) NCT01683253 | Post-Market | Impulse Control Disorder |
Latest
No recent events.
Follow Levodopa Carbidopa on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.